The Architecture of the TIR Domain Signalosome in the Toll-like Receptor-4 Signaling Pathway

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Guven Maiorov, Emine ^a   Keskin, Ozlem ^a   Gursoy, Attila ^a   VanWaes, Carter ^b   Chen, Zhong ^b   Tsai, Chung Jung ^c   Nussinov, Ruth ^c,d  

^a KOÇ UNIVERSITY   (Turkey)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MULTIPROTEIN COMPLEX; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN BINDING; TOLL LIKE RECEPTOR 4;

BIOLOGICAL MODEL; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR MODEL; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; THREE DIMENSIONAL IMAGING;

HUMANS; IMAGING, THREE-DIMENSIONAL; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MULTIPROTEIN COMPLEXES; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84939824619     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13128     Document Type: Article

References (60)

1. Guven Maiorov, E., Keskin, O., Gursoy, A. & Nussinov, R. The structural network of inflammation and cancer: merits and challenges. Semin Cancer Biol 23, 243-51 (2013).
2. Trinchieri, G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol 30, 677-706 (2012).
3. Rakoff-Nahoum, S. & Medzhitov, R. Toll-like receptors and cancer. Nat Rev Cancer 9, 57-63 (2009).
4. Pradere, J. P., Dapito, D. H. & Schwabe, R. F. The Yin and Yang of Toll-like receptors in cancer. Oncogene 33, 3485-95 (2014).
5. Botos, I., Segal, D. M. & Davies, D. R. The structural biology of Toll-like receptors. Structure 19, 447-59 (2011).
6. Valkov, E. et al. Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection. Proc Natl Acad Sci USA 108, 14879-84 (2011).
7. Kenny, E. F. & O'Neill, L. A. Signalling adaptors used by Toll-like receptors: an update. Cytokine 43, 342-9 (2008).
8. Enokizono, Y. et al. Structures and interface mapping of the TIR domain-containing adaptor molecules involved in interferon signaling. Proc Natl Acad Sci USA 110, 19908-13 (2013).
9. Jenkins, K. A. & Mansell, A. TIR-containing adaptors in Toll-like receptor signalling. Cytokine 49, 237-44 (2010).
10. Troutman, T. D. et al. Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt. Proc Natl Acad Sci USA 109, 273-8 (2012).
11. Tseng, P. H. et al. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat Immunol 11, 70-5 (2010).
12. Gay, N. J., Symmons, M. F., Gangloff, M. & Bryant, C. E. Assembly and localization of Toll-like receptor signalling complexes. Nat Rev Immunol 14, 546-58 (2014).
13. Lin, S. C., Lo, Y. C. & Wu, H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465, 885-90 (2010).
14. Dong, C., Davis, R. J. & Flavell, R. A. MAP kinases in the immune response. Annu Rev Immunol 20, 55-72 (2002).
15. O'Neill, L. A., Golenbock, D. & Bowie, A. G. The history of Toll-like receptors-redefining innate immunity. Nat Rev Immunol 13, 453-60 (2013).
16. Hoesel, B. & Schmid, J. A. The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer 12, 86 (2013).
17. Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436-44 (2008).
18. Kagan, J. C. et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 9, 361-8 (2008).
19. Hacker, H., Tseng, P. H. & Karin, M. Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat Rev Immunol 11, 457-68 (2011).
20. Schneider, K., Benedict, C. A. & Ware, C. F. A TRAFfic cop for host defense. Nat Immunol 7, 15-6 (2006).
21. Nunez Miguel, R. et al. A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PLoS One 2, e788 (2007).
22. Bovijn, C. et al. Identification of interaction sites for dimerization and adapter recruitment in Toll/interleukin-1 receptor (TIR) domain of Toll-like receptor 4. J Biol Chem 287, 4088-98 (2012).
23. Luo, J. et al. Lateral clustering of TLR3:dsRNA signaling units revealed by TLR3ecd:3Fabs quaternary structure. J Mol Biol 421, 112-24 (2012).
24. Motshwene, P. G. et al. An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J Biol Chem 284, 25404-11 (2009).
25. Wu, H. Higher-order assemblies in a new paradigm of signal transduction. Cell 153, 287-92 (2013).
26. Ferrao, R., Li, J., Bergamin, E. & Wu, H. Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptor-interleukin-1 receptor superfamily. Sci Signal 5, re3 (2012).
27. Bovijn, C. et al. Identification of binding sites for myeloid differentiation primary response gene 88 (MyD88) and Toll-like receptor 4 in MyD88 adapter-like (Mal). J Biol Chem 288, 12054-66 (2013).
28. Xu, Y. et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408, 111-5 (2000).
29. Lin, Z., Lu, J., Zhou, W. & Shen, Y. Structural insights into TIR domain specificity of the bridging adaptor Mal in TLR4 signaling. PLoS One 7, e34202 (2012).
30. Ohnishi, H. et al. Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling. Proc Natl Acad Sci USA 106, 10260-5 (2009).
31. Piao, W. et al. Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain. Proc Natl Acad Sci USA 110, 19036-41 (2013).
32. Tuncbag, N., Gursoy, A., Nussinov, R. & Keskin, O. Predicting protein-protein interactions on a proteome scale by matching evolutionary and structural similarities at interfaces using PRISM. Nat Protoc 6, 1341-54 (2011).
33. Baspinar, A., Cukuroglu, E., Nussinov, R., Keskin, O. & Gursoy, A. PRISM: a web server and repository for prediction of proteinprotein interactions and modeling their 3D complexes. Nucleic Acids Res 42, W285-9 (2014).
34. Fekonja, O., Bencina, M. & Jerala, R. Toll/interleukin-1 receptor domain dimers as the platform for activation and enhanced inhibition of Toll-like receptor signaling. J Biol Chem 287, 30993-1002 (2012).
35. Janssens, S., Burns, K., Vercammen, E., Tschopp, J. & Beyaert, R. MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB-and AP-1-dependent gene expression. FEBS Lett 548, 103-7 (2003).
36. Basith, S., Manavalan, B., Govindaraj, R. G. & Choi, S. In silico approach to inhibition of signaling pathways of Toll-like receptors 2 and 4 by ST2L. PLoS One 6, e23989 (2011).
37. Kagan, J. C. & Medzhitov, R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125, 943-55 (2006).
38. Ru, H., Zhang, P. & Wu, H. Promiscuity is not always bad. Mol Cell 54, 208-9 (2014).
39. Burns, K. et al. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 273, 12203-9 (1998).
40. Loiarro, M. et al. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound. J Leukoc Biol 82, 801-10 (2007).
41. Roy, A., Kucukural, A. & Zhang, Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5, 725-38 (2010).
42. Khan, J. A., Brint, E. K., O'Neill, L. A. & Tong, L. Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL. J Biol Chem 279, 31664-70 (2004).
43. Snyder, G. A. et al. Crystal structures of the Toll/Interleukin-1 receptor (TIR) domains from the Brucella protein TcpB and host adaptor TIRAP reveal mechanisms of molecular mimicry. J Biol Chem 289, 669-79 (2014).
44. Tuncbag, N., Keskin, O. & Gursoy, A. HotPoint: hot spot prediction server for protein interfaces. Nucleic Acids Res 38, W402-6 (2010).
45. Kiel, C., Verschueren, E., Yang, J. S. & Serrano, L. Integration of protein abundance and structure data reveals competition in the ErbB signaling network. Sci Signal 6, ra109 (2013).
46. Zhang, X., Zhang, J., Zhang, L., van Dam, H. & ten Dijke, P. UBE2O negatively regulates TRAF6-mediated NF-kappaB activation by inhibiting TRAF6 polyubiquitination. Cell Res 23, 366-77 (2013).
47. Ma, Y. et al. Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation. Nat Immunol 5, 380-7 (2004).
48. Tourneur, L. & Chiocchia, G. FADD: a regulator of life and death. Trends Immunol 31, 260-9 (2010).
49. Ye, H. et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418, 443-7 (2002).
50. Park, Y. C. et al. A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. Cell 101, 777-87 (2000).
51. Ye, H., Park, Y. C., Kreishman, M., Kieff, E. & Wu, H. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell 4, 321-30 (1999).
52. Hacker, H. et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204-7 (2006).
53. Ni, C. Z. et al. Molecular basis for CD40 signaling mediated by TRAF3. Proc Natl Acad Sci USA 97, 10395-9 (2000).
54. Ni, C. Z. et al. Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation. J Immunol 173, 7394-400 (2004).
55. Wu, S. et al. LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3. J Biol Chem 280, 33620-6 (2005).
56. Zhang, P. et al. Single amino acid substitutions confer the antiviral activity of the TRAF3 adaptor protein onto TRAF5. Sci Signal 5, ra81 (2012).
57. Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2, 401-4 (2012).
58. Nishi, H. et al. Cancer missense mutations alter binding properties of proteins and their interaction networks. PLoS One 8, e66273 (2013).
59. Stefl, S., Nishi, H., Petukh, M., Panchenko, A. R. & Alexov, E. Molecular mechanisms of disease-causing missense mutations. J Mol Biol 425, 3919-36 (2013).
60. Van Durme, J. et al. A graphical interface for the FoldX forcefield. Bioinformatics 27, 1711-2 (2011).